The French Competition Authority reportedly fined Doctolib €4.66 million for abuse of a dominant position involving exclusivity clauses and the MonDocteur transaction; this is a competition/regulatory risk signal.
SourcePublic company, workplace, funding, and market signals
Updated Aug 5, 2026
Doctolib is a privately held European digital-health company founded in 2013. It provides a patient-facing health companion and a software operating system for healthcare professionals, combining appointment discovery and booking, teleconsultation, communications, practice administration, clinical/financial workflows and AI-enabled assistants. In its 2025 corporate presentation, Doctolib reported 3,000 employees, 420,000 healthcare professionals and 90 million patients across France, Germany, Italy and the Netherlands.
Primary product
A subscription healthcare platform: patients search for and book care, while healthcare professionals use Doctolib’s operating system for scheduling, digital secretariat, telehealth, patient communications, clinical/practice management, billing and increasingly AI-assisted documentation and workflow.
Founded
2013
Headquarters
Levallois-Perret, Île-de-France, France
Team size
2,800–3,600; official 2025 presentation says approximately 3,000
Work style
Flexible
Industry
Healthcare technology / digital health
Sub-industry
Healthcare IT, medical practice-management SaaS, telemedicine and healthcare marketplace
Offices
Business model
Stage
Late-stage venture-backed / private, generating revenue (Series G); no public IPO
Total raised
$866M
Latest round
Series G (additional reported tranche) · Aug 2022
Latest amount
$51M
Series G / strategic investment
Aug 2022 · SanteVet
Mar 2022
Leadership
Co-founder, Chairman and CEO
Alex Kaluzny
Chief Technology Officer
Pierre Vergnes
Group Chief Financial Officer
Matthieu Birach
Chief People Officer
Steve Abou Rjeily
Co-founder and Director of Sales
Mission-led, patient- and healthcare-professional-centric culture. The company describes itself as a medical company, emphasizes humility, perseverance, teamwork, a bold north star and production-grade technology/AI designed to support rather than replace clinicians. Careers materials also emphasize inclusion, women in tech and product, mentoring and continuous learning.
Work style
Flexible
Compensation
Public job postings show benefits and an employee value-sharing plan, but no reliable company-wide salary bands were found. Some international roles advertise relocation support; visa sponsorship is not clearly stated.
Benefits
Pricing
Patients generally use the booking service free of charge; healthcare professionals pay recurring SaaS subscriptions for booking/practice-management, EHR, telemedicine and related modules. Public historical research cited approximately €99–€139/month for core professional booking, with additional annual fees for EHR, telemedicine and devices; current pricing varies by country and product.
Differentiators
Estimated revenue
Approximately $330M–$430M annually (third-party estimates: $331.7M 2023 revenue and $402.6M 2024 revenue; Dealroom reports $100M–$500M).
Estimated monthly visits
33M
The French Competition Authority reportedly fined Doctolib €4.66 million for abuse of a dominant position involving exclusivity clauses and the MonDocteur transaction; this is a competition/regulatory risk signal.
SourceDoctolib acquired Medicus Health, a London-based primary-care software company, to enter the UK/NHS market; reported expansion plans include a London R&D centre and substantial investment.
SourceThe Local France · Aug 2026
Reports on Doctolib’s clinical-AI research program, health-data use, default participation and privacy concerns.
SaaSRise · Jul 2026
Reports a more than £100 million / approximately $125 million investment in Medicus, including a London R&D centre and 150 planned hires.
Noah Intelligence · Jul 2026
Describes Doctolib’s shift toward an industrialized AI platform supporting consultation, phone and patient-assistance products.
Healthcare Digital · May 2026
Covers Doctolib’s Medicus Health acquisition and planned UK/NHS expansion.
155 jobs at Doctolib
Nov 2014 · Bertrand Jelensperger; Pierre Kosciusko-Morizet
Feb 2014
Technology
Customers
Competitors
A reported €300 million secondary share sale valued Doctolib at approximately €3.6 billion, below its approximately €5.8 billion 2022 valuation, indicating a material valuation reset even though it was not a primary financing round.
Doctolib’s clinical-AI research program triggered public debate about default participation, health-data reuse, European hosting and AWS involvement. Doctolib says data is de-identified, encrypted, retained for limited periods and subject to opt-out.
SourceBloomberg · Apr 2026
Reports a secondary share sale valuing Doctolib at approximately €3.6 billion, below its 2022 valuation.
Mar 2022 · Eurazeo; Bpifrance; General Atlantic
Mar 2019 · General Atlantic
Nov 2017 · Eurazeo; Bpifrance
Jan 2017 · Bpifrance
Oct 2015 · Accel